| Name | Title | Contact Details |
|---|
Kersia Group is a global leader in biosecurity and food safety, focused on ensuring the safety of food production, processing, distribution, and consumption. The company aims to create a food-safe world by providing innovative and sustainable solutions that prevent diseases and contamination throughout the food supply chain. Kersia offers a variety of services to enhance food safety and operational performance. These include plant sanitation assessments, inventory usage management, annual cleaning validation, routine plant visits, and sanitation audits. The company collaborates with clients to optimize sanitation programs, ensuring high hygiene standards and compliance with regulatory requirements. With a significant presence in the United States and headquartered in France, Kersia USA specifically addresses food safety challenges in the meat and poultry processing sectors. The company is dedicated to supporting various industries, including dairy and healthcare, by delivering tailored solutions that enhance operational efficiency.
We are a global precision engineering company manufacturing, supplying and distributing cutting tools to leading industrial companies from our facilities around the world. With a legacy based on commitment to quality, we have been serving our customers from our headquarters in Cavan, Ireland for almost 60 years.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Elementary is a company specializing in advanced machine vision inspection, utilizing AI and automation to enhance manufacturing processes. Founded in mid-2017 by experienced professionals from various sectors, the company aims to develop a new generation of manufacturing products that rely on computer vision and AI. Their platform automates traceability scans and integrates AI, machine vision, and automation into production lines. This approach focuses on improving quality, traceability, and root cause analyses, making manufacturing processes more efficient. Elementary emphasizes a human-in-the-loop strategy, enhancing collaboration between humans and machines to optimize working conditions and outcomes. Based in Los Angeles, California, Elementarys team includes roboticists, computer scientists, designers, and engineers. The company has attracted significant funding, including a $30 million Series B round led by Tiger Global, to support its innovative solutions in manufacturing. Their technology is utilized by notable clients across various industries, including Toyota in the automotive sector.